Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
MS14 - IO in Early Stage NSCLC
- 10:30 - 12:00
- 9/25/2018
- Location: Room 107
- Type: Mini Symposium
- Track: Immunooncology
-
+
MS14.01 - Basic Science Rationale of IO in Early Stage NSCLC?
10:30 - 10:45 | Presenter: Johan F. Vansteenkiste | Author(s): Christophe A. Dooms
- Abstract
No abstract available for this presentation
-
+
MS14.02 - Adjuvant / Neoadjuvant IO Therapy
10:45 - 11:00 | Presenter: Julie R. Brahmer
- Abstract
No abstract available for this presentation
-
+
MS14.03 - Concerns About IO for the Thoracic Surgeon?
11:00 - 11:15 | Presenter: Bernward Passlick
- Abstract
No abstract available for this presentation
-
+
MS14.04 - IO - New Standards in Stage III NSCLC
11:15 - 11:30 | Presenter: Rafal Dziadziuszko
- Abstract
No abstract available for this presentation
-
+
MS14.05 - Do Biomarkers used in Metastatic Setting Apply in Earlier Stages
11:30 - 11:45 | Presenter: Naiyer A Rizvi
- Abstract
No abstract available for this presentation
-
+
MS14.06 - Q&A
11:45 - 12:00
- Abstract
No abstract available for this presentation
-
+
MS15 - Disruptive Technology and Lung Cancer Risk
- 10:30 - 12:00
- 9/25/2018
- Location: Room 201 BD
- Type: Mini Symposium
- Track: Prevention and Tobacco Control
-
+
MS15.01 - Just Water Vapor? Toxicology Perspectives on Electronic Cigarettes
10:30 - 10:45 | Presenter: Maciej Lukasz Goniewicz
- Abstract
No abstract available for this presentation
-
+
MS15.02 - PRO- Electronic Cigarettes: A Cessation Tool
10:45 - 11:00 | Presenter: K. Michael Cummings
- Abstract
No abstract available for this presentation
-
+
MS15.03 - CON- Electronic Cigarettes: Not Evidence Based Cessation
11:00 - 11:15 | Presenter: Alison Wallace
- Abstract
No abstract available for this presentation
-
+
MS15.04 - The Rise of Heat-Not Burn Tobacco in Japan: A “Hot” Issue for Tobacco Control
11:15 - 11:30 | Presenter: Junji Yoshida
- Abstract
No abstract available for this presentation
-
+
MS15.05 - Heat-Not-Burn Tobacco: Real Risk Reduction or Industry’s Next Promise
11:30 - 11:45 | Presenter: Carolyn Dresler
- Abstract
Loading... -
+
MS15.06 - Q&A
11:45 - 12:00
- Abstract
No abstract available for this presentation
-
+
OA10 - Right Patient, Right Target & Right Drug - Novel Treatments and Research Partnerships
- 10:30 - 12:00
- 9/25/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA10.01 - Patient Preferences for Tyrosine Kinase Inhibitor Treatments for EGFR Mutation Positive Metastatic NSCLC
10:30 - 10:40 | Presenter: John F.P. Bridges | Author(s): Marie De La Cruz, Melissa Pavilack, Emuella Flood, Ellen Janssen, Nabil Chehab, Ancilla W. Fernandes
- Abstract
Loading... -
+
OA10.02 - Oncogene-Driven Patient Groups: A New Era For Research Partnerships
10:40 - 10:50 | Presenter: Janet Freeman-Daily | Author(s): Ivy Elkins, Laura Greco, Marcia K Horn, Bonnie Addario, David LeDuc, Robert C. Doebele, Christine Lovly
- Abstract
Loading... -
+
OA10.03 - Discussant - OA 10.01, OA 10.02
10:50 - 11:05 | Presenter: Zofia Piotrowska
- Abstract
No abstract available for this presentation
-
+
OA10.04 - Afatinib With or Without Cetuximab for EGFR-Mutant Non-Small Cell Lung Cancer: Safety and Efficacy Results from SWOG S1403
11:05 - 11:15 | Presenter: Sarah B Goldberg | Author(s): Mary W. Redman, Rogerio Lilenbaum, Katerina Politi, Thomas E. Stinchcombe, Leora Horn, Everett H. Chen, Sandeep Mashru, Scott N. Gettinger, Mary Ann Melnick, Jieling Miao, James Moon, Karen Kelly, David R. Gandara
- Abstract
Loading... -
+
OA10.05 - An Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients with Uncommon EGFR Mutation(KCSG-LU15-09)
11:15 - 11:25 | Presenter: Jang Ho Cho | Author(s): Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Keon Uk Park, Eun Joo Kang, Yoon Hee Choi, Ki Hwan Kim, Ho Jung, An An, Hyun Woo Lee, Myung-Ju Ahn
- Abstract
Loading... -
+
OA10.06 - A First-in-Human Phase 1 Trial of the EGFR-cMET Bispecific Antibody JNJ-61186372 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
11:25 - 11:35 | Presenter: Keunchil Park | Author(s): Myung-Ju Ahn, Se-Hoon Lee, Hye Ryun Kim, Min Hee Hong, Dawn Millington, Martin Curtis, Spyros Triantos, Sandra Chaplan, Nahor Haddish-Berhane, Roland Knoblauch, Zuleima Aguilar, Sylvie Laquerre, Matthew V. Lorenzi, Byoung Chul Cho
- Abstract
Loading... -
+
OA10.07 - Resistance Mechanisms of Osimertinib in Chinese Non-Small Cell Lung Cancer Patients: Analysis from AURA17 Trial
11:35 - 11:45 | Presenter: Caicun Zhou | Author(s): Min Hu, Xuehua Zhu, Yun Sun, Xuesong Lu, Jia Wang, Mengzhao Wang, Ying Cheng, Yuan Chen, Yanqiu Zhao, Yuan-Kai Shi, You Lu, Meiqi Shi, He-Long Zhang, Xiangning Huang, Zheng Wang, Zhijie Ding, Heyan Li, George Chen, Yi-Long Wu
- Abstract
Loading... -
+
OA10.08 - Discussant - OA 10.04, OA 10.05, OA 10.06, OA 10.07
11:45 - 12:00 | Presenter: Linda Coate
- Abstract
No abstract available for this presentation
-
+
PC05 - Optimizing Clinical Trial Design in NSCLC
- 10:30 - 12:00
- 9/25/2018
- Location: Room 205 AC
- Type: Pro-Con Session
- Track: Advanced NSCLC
-
+
PC05.00 - Introduction with Poll Questions
10:30 - 10:35 | Presenter: Pilar Garrido, Luis Ubillos
- Abstract
No abstract available for this presentation
-
+
PC05.01 - Debate 1: Which is Most Important Efficacy Endpoint in First Line Trials in Advanced NSCLC PFS or OS - Point of View: PFS
10:35 - 10:50 | Presenter: Mary O’brien
- Abstract
No abstract available for this presentation
-
+
PC05.02 - Debate 1: Which is Most Important Efficacy Endpoint in First Line Trials in Advanced NSCLC PFS or OS - Point of View: OS
10:50 - 11:05 | Presenter: Yu Shyr
- Abstract
No abstract available for this presentation
-
+
PC05.03 - Discussion
11:05 - 11:10
- Abstract
No abstract available for this presentation
-
+
PC05.04 - Debate 2: Patient Reported Outcomes Should Be the Most Important Endpoint in Trials in the Palliative Setting - YES
11:10 - 11:25 | Presenter: Maurice Pérol
- Abstract
No abstract available for this presentation
-
+
PC05.05 - Debate 2: Patient Reported Outcomes Should Be the Most Important Endpoint in Trials in the Palliative Setting - NO
11:25 - 11:40 | Presenter: Rathi N Pillai
- Abstract
No abstract available for this presentation
-
+
PC05.06 - Discussion
11:40 - 11:45
- Abstract
No abstract available for this presentation
-
+
PC05.07 - Let's Not Forget Chemo-Regret
11:45 - 11:55 | Presenter: Patricia J. Hollen
- Abstract
No abstract available for this presentation
-
+
PC05.08 - Discussion
11:55 - 12:00
- Abstract
No abstract available for this presentation
-
+
MA15 - Colliding Approaches - EGFR and Immunotherapy
- 13:30 - 15:00
- 9/25/2018
- Location: Room 107
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA15.01 - Strong PD-L1 Expression Predicts Poor Response and de Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients with EGFR Mutation
13:30 - 13:35 | Presenter: Shan Su | Author(s): Zhong-Yi Dong, Xie Zhi, Jian Su, Zhi-Hong Chen, Jin-Ji Yang, Hai-Yan Tu, Qing Zhou, Wen Zhao Zhong, Xu-Chao Zhang, Yi-Long Wu
- Abstract
Loading... -
+
MA15.02 - Long-Term Safety and Clinical Activity Results from a Phase Ib Study of Erlotinib Plus Atezolizumab in Advanced NSCLC
13:35 - 13:40 | Presenter: Charles M. Rudin | Author(s): Andres Cervantes, Afshin Dowlati, Benjamin Besse, Brigette Ma, Daniel B Costa, Peter Schmid, Rebecca Heist, Victoria M. Villaflor, Indrani Sarkar, Genevive Hernandez, Paul Foster, Jessica Spahn, Carol O'Hear, Scott N. Gettinger
- Abstract
Loading... -
+
MA15.03 - PD-L1 Expression in Untreated EGFRm Advanced NSCLC and Response to Osimertinib and SoC EGFR-TKIs in the FLAURA Trial
13:40 - 13:45 | Presenter: Suresh S. Ramalingam | Author(s): Helen Brown, Johan F. Vansteenkiste, Kazuhiko Nakagawa, Manuel Cobo Dols, Thomas John, Craig Barker, Alexander Kohlmann, Alexander Todd, Matilde Saggese, Juliann Chmielecki, Aleksandra Markovets
- Abstract
Loading... -
+
MA15.04 - Discussant - MA 15.01, MA 15.02, MA 15.03
13:45 - 14:00 | Presenter: Adrian Sacher
- Abstract
No abstract available for this presentation
-
+
MA15.05 - The Mutational Profiles of EGFR 19 Exon Deletion and 21 Exon L858R Mutation and Their Association with Primary Response to EGFR-TKIs
14:00 - 14:05 | Presenter: Wenhua Liang | Author(s): Caichen Li, Yi Zhao, Jianxing He
- Abstract
Loading... -
+
MA15.06 - Circulating Tumor DNA Portrays the Resistance Landscape to a Novel Third Generation EGFR Inhibitor, AC0010
14:05 - 14:10 | Presenter: Yi-Chen Zhang | Author(s): Qing Zhou, Zhi-Hong Chen, Chong-Rui Xu, Jin -Ji Yang, Xu-Chao Zhang, Xiao-Yan Bai, Hong-Hong Yan, Zhi Xie, Wen -Feng Li, Shannon Chuai, Jun-Yi Ye, Han Zhang-Han, Zhou Zhang, Yi-Long Wu
- Abstract
Loading... -
+
MA15.07 - Different Responses to Osimertinib in Primary and Acquired EGFR T790M-Mutant NSCLC Patients
14:10 - 14:15 | Presenter: Shuyuan Wang | Author(s): Bo Zhang, Baohui Han
- Abstract
Loading... -
+
MA15.08 - Discussant - MA 15.05, MA 15.06, MA 15.07
14:15 - 14:30 | Presenter: Charu Aggarwal
- Abstract
No abstract available for this presentation
-
+
MA15.09 - Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR Mutant Advanced NSCLC Patients Treated with First-Line EGFR-TKIs
14:30 - 14:35 | Presenter: Chunxia Su | Author(s): Tao Jiang, Jing Zhao, Xuefei Li, Caicun Zhou
- Abstract
Loading... -
+
MA15.10 - Loss of T790M Mutation is Associated with Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M
14:35 - 14:40 | Presenter: Sha Zhao | Author(s): Tao Jiang, Xuefei Li, Chao Zhao, Chunxia Su, Shengxiang Ren, Caicun Zhou
- Abstract
Loading... -
+
MA15.11 - Real World Biomarker Testing and Treatment Patterns in Patients with Advanced NSCLC Receiving EGFR-TKIs
14:40 - 14:45 | Presenter: Anne Chiang | Author(s): Ancilla W. Fernandes, Melissa Pavilack, Jennifer W. Wu, Francois Laliberté, Mei Sheng Duh, Nabil Chehab, Janakiraman Subramanian
- Abstract
Loading... -
+
MA15.12 - Discussant - MA 15.09, MA 15.10, MA 15.11
14:45 - 15:00 | Presenter: Joel W. Neal
- Abstract
No abstract available for this presentation
-
+
MA16 - Novel Mechanisms for Molecular Profiling
- 13:30 - 15:00
- 9/25/2018
- Location: Room 203 BD
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
-
+
MA16.01 - Frequency and Genomic Context of Emerging Markers for Molecular Testing in Lung Adenocarcinoma in Cell-Free DNA NGS Analysis
13:30 - 13:35 | Presenter: Vincent K Lam | Author(s): Lesli Ann Kiedrowski, Zofia Piotrowska, Anne S. Tsao, Ashley M. Wells, Richard B Lanman, Vassiliki A Papadimitrakopoulou, Rebecca J Nagy
- Abstract
Loading... -
+
MA16.02 - Prospective Clinical Validation of the InVisionFirst™ ctDNA Assay for Molecular Profiling of Patients with Advanced NSCLC
13:35 - 13:40 | Presenter: Ramaswamy Govindan | Author(s): Michael A. Pritchett, Ross Camidge, Manu Patel, Jamil Khatri, Steven Boniol, Elke K. Friedman, Abderrahim Khomani, Samir Dalia, Katherine Baker-Neblett, Vincent Plagnol, Karen Howarth, Nitzan Rosenfeld, Clive Morris
- Abstract
Loading... -
+
MA16.03 - Discussant - MA 16.01, MA 16.02
13:40 - 13:55 | Presenter: Geoffrey R. Oxnard
- Abstract
No abstract available for this presentation
-
+
MA16.04 - Clinical and Molecular Characteristics of EGFR Mutant Lung Cancers with Concurrent TP53 and RB1 Mutations.
13:55 - 14:00 | Presenter: Michael Offin | Author(s): Megan Tenet, Ronglai Shen, Natasha Rekhtman, Hira Rizvi, Matthew D. Hellmann, Maria E Arcila, Marc Ladanyi, Charles M. Rudin, Mark G Kris, Helena Yu
- Abstract
Loading... -
+
MA16.05 - MET Kinase Domain Rearrangements (KDRE) in Non-Small Cell Lung Cancer (NSCLC) Identified Through Comprehensive Genomic Profiling (CGP)
14:00 - 14:05 | Presenter: Sai-Hong Ignatius Ou | Author(s): Alexa B Schrock, Dean Pavlick, Mark Rosenzweig, Rachel L Erlich, Lee A Albacker, Garrett M Frampton, Jeffrey S. Ross, Vincent A Miller, Siraj M Ali
- Abstract
Loading... -
+
MA16.06 - EGFR Clonality and Tumor Mutation Burden (TMB) by Circulating Tumor DNA (ctDNA) Sequencing in Advanced Non-Small Cell Lung Cancer (NSCLC)
14:05 - 14:10 | Presenter: Xinghao Ai | Author(s): Yingcheng Lin, Jiexia Zhang, Congying Xie, Anwen Liu, Xiaohua Hu, Qiong Zhao, Yuansheng Zang, Chuangzhou Rao, Xiaohua Hu, Lianpeng Chang, Qin Li, Yanfang Guan, Rongrong Chen, Xin Yi, Shun Lu
- Abstract
Loading... -
+
MA16.07 - Discussant - MA 16.04, MA 16.05, MA 16.06
14:10 - 14:25 | Presenter: Ben J Solomon
- Abstract
No abstract available for this presentation
-
+
MA16.08 - Clinical Utility of Detecting ROS1 Genetic Alterations in Plasma
14:25 - 14:30 | Presenter: Ibiayi Dagogo-Jack | Author(s): Rebecca J Nagy, Lorin A Ferris, Jessica Jiyeong Lin, Justin F Gainor, Richard B Lanman, Alice T. Shaw
- Abstract
Loading... -
+
MA16.09 - Feasibility, Clinical Relevance of ALK/ROS1 Fusion Variant Detection by Liquid Biopsy in Advanced Non-Small Cell Lung Cancer
14:30 - 14:35 | Presenter: Aurélie Swalduz | Author(s): Laura Mezquita, Sandra Ortiz-Cuaran, Cecile Jovelet, Virginie Avrillon, David Planchard, Solène Marteau, Gonzalo Recondo, Séverine Martinez, Karen Howarth, Vincent Plagnol, Clive Morris, Emma Green, Luc Odier, Ludovic Lacroix, Stéphane Hominal, Etienne Rouleau, Claire Tissot, Caroline Caramella, Pierre Fournel, Luc Friboulet, Maurice Pérol, Benjamin Besse, Pierre Saintigny
- Abstract
Loading... -
+
MA16.10 - Clinical Utility of Cerebrospinal Fluid Cell-Free DNA for Clarifying Genetic Features of Leptomeningeal Metastases in ALK Rearrangement NSCLC
14:35 - 14:40 | Presenter: Meimei Zheng | Author(s): Yangsi Li, Ben-Yuan Jiang, Hai-Yan Tu, Xu-Chao Zhang, Jun-Yi Ye, Wen-Fang Tang, Shannon Chuai, Yi-Long Wu
- Abstract
Loading... -
+
MA16.11 - Discussant - MA 16.08, MA 16.09, MA 16.10
14:40 - 14:55 | Presenter: Robert C. Doebele
- Abstract
No abstract available for this presentation
-
+
MA16.12 - Q&A
14:55 - 15:00
- Abstract
No abstract available for this presentation
-
+
MA17 - New Methods to Improve Lung Cancer Patients Outcomes
- 13:30 - 15:00
- 9/25/2018
- Location: Room 205 AC
- Type: Mini Oral Abstract Session
- Track: Nursing and Allied Professionals
-
+
MA17.01 - A Sense of Understanding and Belonging When Life Is at Stake – Operable Lung Cancer Patients’ Lived Experiences of Participation in Exercise
13:30 - 13:35 | Presenter: Malene Missel | Author(s): Mai Nanna Schoenau, Britt Borregaard
- Abstract
Loading... -
+
MA17.02 - Early Accrual to a Precision Lung Cancer Survivorship Intervention: The Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program
13:35 - 13:40 | Presenter: Jamie L Studts | Author(s): Jessica L Burris, Michael A Andrykowski, Tara Schapmire, Barbara Head, Maureen Rigney, Angela Meredith Criswell, Susanne M Arnold, Allyson R Yates, Courtney Blair, Amy Christian
- Abstract
Loading... -
+
MA17.03 - Shared Decision-Making for Patients with Advanced Non-Small Cell Lung Cancer
13:40 - 13:45 | Presenter: Mette Kargo Jensen | Author(s): Karin Piil, Gitte Fredberg Persson, Seppo W Langer, Mette Vinter, Katrina Pitt Winther, Susanne Friis-Haché, Mette Pøhl
- Abstract
Loading... -
+
MA17.04 - Discussant - MA 17.01, MA 17.02, MA 17.03
13:45 - 14:00 | Presenter: Anne Fraser
- Abstract
No abstract available for this presentation
-
+
MA17.05 - Development of a Telephone Clinic for Patients Undergoing Long Term Follow-Up After Thoracic Surgery
14:00 - 14:05 | Presenter: Jenny Mitchell | Author(s): Calum Buchanan, Sarah Malone, Francesco Di Chiara, Dionisios Stavroulias, Elizabeth Belcher
- Abstract
Loading... -
+
MA17.06 - The Specialist Lung Cancer Nurse and Self-Management for People Living with Lung Cancer: A Model of Engagement
14:05 - 14:10 | Presenter: Vanessa Nicole Brunelli | Author(s): Patsy Yates, Carol Windsor
- Abstract
Loading... -
+
MA17.07 - Nurse-Led Telehealth Clinic in Treatment Monitoring and Follow Up
14:10 - 14:15 | Presenter: Sarah Louise Cubbin | Author(s): Michael Brada
- Abstract
Loading... -
+
MA17.08 - Discussant - MA 17.05, MA 17.06, MA 17.07
14:15 - 14:30 | Presenter: Melissa Culligan
- Abstract
No abstract available for this presentation
-
+
MA17.09 - Remote Symptom Reporting for Tele-Nursing Team in Thoracic Oncology Clinics: Environmental Scan and Stakeholder Engagement
14:30 - 14:35 | Presenter: Simranjit Kooner | Author(s): Jennifer Harris, Suheon Lee, Catherine De Guia, Doris Howell, Geoffrey Liu
- Abstract
Loading... -
+
MA17.10 - The Use of Technology in the Delivery of Supportive Care of Lung Cancer Patients After Treatment
14:35 - 14:40 | Presenter: Pamela Rose | Author(s): Heather Quail, John McPhelim, Mhairi Simpson
- Abstract
Loading... -
+
MA17.11 - Multi-Centred, Prospective, Audit to Identify Readmission Causes and Complications Within 30 of Primary Lung Cancer Surgery
14:40 - 14:45 | Presenter: Amy Kerr | Author(s): Maureen King, Sandra Dixon, Sarah Taylor, Alison Smith, Charlotte Merriman, Jenny Mitchell, Verity Hunter
- Abstract
Loading... -
+
MA17.12 - Discussant - MA 17.09, MA 17.10, MA 17.11
14:45 - 15:00 | Presenter: Mary Duffy
- Abstract
No abstract available for this presentation
-
+
MA18 - Modelling, Decision-Making and Population-Based Outcomes
- 13:30 - 15:00
- 9/25/2018
- Location: Room 201 F
- Type: Mini Oral Abstract Session
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
MA18.01 - Non-Small Cell Lung Cancer Risk Assessment with Artificial Neural Networks
13:30 - 13:35 | Presenter: Tafadzwa Lawrence Chaunzwa | Author(s): Yiwen Xu, David C Christiani, Andrea Shafer, Nancy Diao, Michael Lanuti, Raymond Mak, Hugo Aerts
- Abstract
Loading... -
+
MA18.03 - How in the Real World Are Lung Cancer Patients Treated? The Ontario, Canada Experience
13:35 - 13:40 | Presenter: William Kenneth Evans | Author(s): William Flanagan, Cindy Gauvreau, Phongsack Manivong, Saima Memon, Natalie Fitzgerald, John R Goffin, Rochelle Garner, Edwin Khoo, Nicole Mittmann
- Abstract
Loading... -
+
MA18.04 - Discussant - MA 18.01, MA 18.03
13:40 - 13:55 | Presenter: Shalini K Vinod
- Abstract
No abstract available for this presentation
-
+
MA18.05 - Characteristics and Long-Term OS of Non-Small Cell Lung Cancer Patients Receiving EGFR Tyrosine Kinase Inhibitor Treatment
13:55 - 14:00 | Presenter: Michael Bergqvist | Author(s): Helene Nordahl Christensen, Fredrik Wiklund, Stefan Bergström
- Abstract
Loading... -
+
MA18.06 - Patterns of Lung Cancer Care in the United States: Developments and Disparities
14:00 - 14:05 | Presenter: Erik Ferdinand Blom | Author(s): Kevin ten Haaf, Douglas Arenberg, Harry J De Koning
- Abstract
Loading... -
+
MA18.07 - Awareness of the Harms of Continued Smoking Among Lung Cancer (LC) Survivors
14:05 - 14:10 | Presenter: Lawson Eng | Author(s): Sophia Liu, Delaram Farzanfar, Devon Alton, Elliot C Smith, Alexandra McCartney, Sabrina Yeung, Amedra Basgaran, Karmugi Balaratnam, Katie Mattina, Christopher Harper, Rahul Mohan, M Catherine Brown, Andrew Hope, Penelope Bradbury, Adrian Sacher, Natasha B Leighl, Frances A Shepherd, Andrea Bezjak, Doris Howell, Jennifer M Jones, Wei Xu, David P Goldstein, William Kenneth Evans, Peter Selby, Meredith Giuliani, Geoffrey Liu
- Abstract
Loading... -
+
MA18.08 - Discussant - MA 18.05, MA 18.06, MA 18.07
14:10 - 14:25 | Presenter: Vera Hirsh
- Abstract
No abstract available for this presentation
-
+
MA18.09 - Predictors of Health Utility Scores (HUS) in Advanced EGFR-Mutated NSCLC.
14:25 - 14:30 | Presenter: Shirley Xue Jiang | Author(s): Manjusha Hurry, Katrina Hueniken, M Catherine Brown, Mindy Liang, Devalben Patel, Catherine Labbe, Lawson Eng, Hiten Naik, Penelope Bradbury, Natasha B Leighl, Frances A Shepherd, Wei Xu, Geoffrey Liu, Ryan N. Walton, Grainne M O'Kane
- Abstract
Loading... -
+
MA18.10 - Evolving Immunotherapy Practice Patterns in Advanced NSCLC: Analysis of an Online Treatment Decision Tool
14:30 - 14:35 | Presenter: David R. Gandara | Author(s): Timothy A Quill, Martin J. Edelman, Suresh S. Ramalingam, Heather A Wakelee, Howard West, Kevin L Obholz
- Abstract
Loading... -
+
MA18.11 - Implementing a Comprehensive National Audit of Lung Cancer Surgery: The English Lung Cancer Clinical Outcomes Publication (LCCOP) Project
14:35 - 14:40 | Presenter: Doug West | Author(s): Richard Page, Neal Navani, Susan V Harden, Aamir Khakwani, Richard Hubbard, Paul Beckett
- Abstract
Loading... -
+
MA18.12 - Discussant - MA 18.09, MA 18.10, MA 18.11
14:40 - 14:55 | Presenter: Martin R Stockler
- Abstract
No abstract available for this presentation
-
+
MA18.12a - Q&A
14:55 - 15:00
- Abstract
No abstract available for this presentation
-
+
MS16 - Implementation of Lung Cancer Screening
- 13:30 - 15:00
- 9/25/2018
- Location: Room 206 F
- Type: Mini Symposium
- Track: Screening and Early Detection
-
+
MS16.01 - CMS Approved ACR Lung Cancer Screening Registry in the United States
13:30 - 13:45 | Presenter: Ella Kazerooni
- Abstract
No abstract available for this presentation
-
+
MS16.02 - NELCIN B3 Screening Program in China
13:45 - 14:00 | Presenter: Qinghua Zhou
- Abstract
No abstract available for this presentation
-
+
MS16.03 - Recruitment Strategies for the Lung Cancer Screening
14:00 - 14:15 | Presenter: Gail Elizabeth Darling
- Abstract
No abstract available for this presentation
-
+
MS16.04 - National Lung Screening Program in Taiwan
14:15 - 14:30 | Presenter: Pan-Chyr Yang
- Abstract
No abstract available for this presentation
-
+
MS16.05 - Optimal Approach to Integrate Smoking Cessation into Screening Program
14:30 - 14:45 | Presenter: Matthew Eric Callister
- Abstract
No abstract available for this presentation
-
+
MS16.06 - Q&A
14:45 - 15:00
- Abstract
No abstract available for this presentation
-
+
MS17 - Life After Lung Cancer: Survivorship
- 13:30 - 15:00
- 9/25/2018
- Location: Room 206 AC
- Type: Mini Symposium
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
MS17.01 - Unmet needs and QOL of Lung Cancer Survivors
13:30 - 13:45 | Presenter: Meredith Giuliani
- Abstract
No abstract available for this presentation
-
+
MS17.02 - Financial Toxicity and Out of Pocket Costs
13:45 - 14:00 | Presenter: Bishal Gyawali
- Abstract
No abstract available for this presentation
-
+
MS17.03 - Surveillance & Second Primary Malignancies in Lung Cancer Survivors
14:00 - 14:15 | Presenter: Virginie Westeel
- Abstract
No abstract available for this presentation
-
+
MS17.04 - How Important Is Tobacco Cessation as Part of Lung Cancer Treatment?
14:15 - 14:30 | Presenter: Clarissa Baldotto
- Abstract
No abstract available for this presentation
-
+
MS17.05 - Discussion
14:30 - 15:00
- Abstract
No abstract available for this presentation